| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/22/2001 | CN1309721A Heteroduplex mutational vectors and use thereof in bacteria |
| 08/22/2001 | CN1309720A Virulence-associated nucleic acid sequences and uses thereof |
| 08/22/2001 | CN1309717A Cell-free chimeraplasty and fukaryotic use of heteroduplex mutational vector |
| 08/22/2001 | CN1309716A Expression system contg. chimeric promoters with binding sites for recombinant transcription factors |
| 08/22/2001 | CN1309715A Process for selection of transgenic cells in meristematic region of cotton, coffee, cocoa, banana or grape |
| 08/22/2001 | CN1309714A Methods and means to modulate programmed cell death in eukaryotic cells |
| 08/22/2001 | CN1309713A Recombination repair gene MIM from Arabidopsis thaliana |
| 08/22/2001 | CN1309712A Method of making proteins in transformed yeast cells |
| 08/22/2001 | CN1309711A Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal nutant cells |
| 08/22/2001 | CN1309710A Genomic sequences upstream of coding region of IFN-alpha 2 gene for protein production and delivery |
| 08/22/2001 | CN1309709A Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/22/2001 | CN1309708A Postweaning multisystemic wasting syndrome virus from pigs |
| 08/22/2001 | CN1309707A BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 08/22/2001 | CN1309706A Compound from moraxella catarrhalis |
| 08/22/2001 | CN1309705A IL-2 selective agonists and antagonists |
| 08/22/2001 | CN1309704A Promotor sequences expressed in anthers and pollens |
| 08/22/2001 | CN1309703A Mutants of mycobacterium species and use of same for screening for antibiotics vectors |
| 08/22/2001 | CN1309702A Glutaminase, gene thereof and process for producing same |
| 08/22/2001 | CN1309701A Starch debranching enzymes |
| 08/22/2001 | CN1309700A Glucoamylase variants |
| 08/22/2001 | CN1309699A Phytase variants |
| 08/22/2001 | CN1309665A Antibodies capable of detecting beer spoilage lactic acid bacteria and detecting method using same, and reagent kit with same |
| 08/22/2001 | CN1309664A Anti hepatitis C virus antibody and uses thereof |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309659A Phosphorous organic compounds and their use |
| 08/22/2001 | CN1309184A Operation of enzymatic vitality of protoporphyrin primary oxidase in eukaryote |
| 08/22/2001 | CN1309183A Process for preparing bio-degradable plastics by construction of genetically engineered cytoalgae |
| 08/22/2001 | CN1309182A Cholesterol regulatory factor binding protein and its coding sequence |
| 08/22/2001 | CN1309181A Transgenic mammal cell line to efficiently express surface S (main protein) and pre-S1 (macro protein) fusion antigen of hepatitis B |
| 08/22/2001 | CN1309178A Full-synthetic culture medium and its application |
| 08/22/2001 | CN1309177A Se-enriched high-biomass yeast and its preparing process |
| 08/22/2001 | CN1309135A Novel human protein able to suppress cancer cell growth and its coding sequence |
| 08/22/2001 | CN1309134A Novel human Kruppel homologous protein and its coding sequence |
| 08/22/2001 | CN1308967A Method for producing transgenic plant to express protein in hepatitis B virus envelope and its products |
| 08/22/2001 | CN1069925C Salmonella rDNA spacer nucleic acid molecular probe and its using method |
| 08/21/2001 | USRE37336 Method for providing hyaluronic acid |
| 08/21/2001 | US6278042 Plant arsenic transporters |
| 08/21/2001 | US6278041 Nucleotide sequence; for transgenic plants with insect resistance |
| 08/21/2001 | US6278040 Receptor-deficient mice and cell lines derived therefrom, and uses thereof |
| 08/21/2001 | US6278039 C. elegans deletion mutants |
| 08/21/2001 | US6277981 Method for design and selection of efficacious antisense oligonucleotides |
| 08/21/2001 | US6277980 Mixed backbone oligonucleotide analog having nucleotide sequence complementary to e6/e7 genes; has phosphorothioate bonds and at least one other phosphorus linking group or modification; viricides |
| 08/21/2001 | US6277979 KIAA0551 polynucleotides and polypeptides use |
| 08/21/2001 | US6277978 KVLQT1—a long QT syndrome gene |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277976 Or-1, an orphan receptor belonging to the nuclear receptor family |
| 08/21/2001 | US6277975 Fusions of P-selectin ligand protein and polynucleotides encoding same |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277971 Dna which codes for nap protein of defined amino acid sequence; diagnosis and treatment of acquired immune deficiency syndrome (aids) |
| 08/21/2001 | US6277970 PRP-like gene |
| 08/21/2001 | US6277967 Having alternating phosphodiester and phosphorothioate linkages; nuclease resistant with reduced side effects; diagnosis; antisense agents |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277964 Anti-PAH monoclonal antibodies and cell lines producing the same |
| 08/21/2001 | US6277963 Antibodies directed toward extracellular signal-related kinases |
| 08/21/2001 | US6277962 Receptor on the surface of activated t-cells: act-4 |
| 08/21/2001 | US6277960 Amino acid sequence of g protein coupled receptor; treatment of eating disorders, asthma, parkinson's disease, cardiovascular and nervous system disorders, huntington's disease, tourett's syndrome, and others; diagnosis |
| 08/21/2001 | US6277959 Isolated mammalian membrane protein genes; related reagents |
| 08/21/2001 | US6277832 Anticarcinogenic agents |
| 08/21/2001 | US6277824 Enhancing or inhibiting cadherin-mediated functions comprising a his-ala-val sequence binding motif, an peptidomimetic or an antibody that binds to such a motif |
| 08/21/2001 | US6277823 Isolated from xenorhabdus nematophilus, xenorhabdus poinarii, and photorhabdus luminescens to control insect pests or in transgenic plants to confer insect resistance |
| 08/21/2001 | US6277822 Family of peptides known as xenoxins |
| 08/21/2001 | US6277821 For treating gramnegative and mycobacterium infections; endotoxin and heparin neutralization |
| 08/21/2001 | US6277817 Human lactoferrin |
| 08/21/2001 | US6277814 Enhancement of growth in plants |
| 08/21/2001 | US6277806 Enzyme fused to a heavy chain immunoglobulin raised in camelidae and has a specificity for non-colored compounds present in stains and fabrics, surfactant and transition metal catalyst |
| 08/21/2001 | US6277648 Process and a device for the isolation of cell components such as nucleic acids from natural sources |
| 08/21/2001 | US6277640 Antisense modulation of Her-3 expression |
| 08/21/2001 | US6277639 Methods for multifragment sexual cloning and mutation mapping |
| 08/21/2001 | US6277638 Producing nucleic acid fragments or polynucleotides conferring desired phenotype which encodes mutant proteins via repeated cycles of in vitro or in vivo recombination (mutagenesis, shuffling, and selection) |
| 08/21/2001 | US6277636 Antisense inhibition of MADH6 expression |
| 08/21/2001 | US6277635 Use of interleukin-10 to produce a population of suppressor cells |
| 08/21/2001 | US6277634 Hybridized with target rna to be cleaved; medical diagnosis or gene therapy, drugs |
| 08/21/2001 | US6277633 Lentivirus-based gene transfer vectors |
| 08/21/2001 | US6277632 Highly efficient, rapid linkage of nucleic acid components in a predetermined order to produce multicomponent construct (each component having single stranded terminal sequence that allows for specific annealing) |
| 08/21/2001 | US6277631 Recombinant yeast (schizosaccharomyces pombe or saccharomyces cerevisiae) expression vectors |
| 08/21/2001 | US6277625 For control of diseases caused by the soil-borne fungus, rhizoctonia and diseases caused by gaeumannomyces graminis or pythium |
| 08/21/2001 | US6277623 Vector for use as tool in genetic engineering |
| 08/21/2001 | US6277621 Artificial chromosome constructs containing foreign nucleic acid sequences |
| 08/21/2001 | US6277620 Polypeptide for the prevention of bacterial infection; bactericides; for vaccine development |
| 08/21/2001 | US6277618 Enzymatic protein; for use in diagnosis of blood disorders; for use in detection of modulators of blood coagulation |
| 08/21/2001 | US6277615 (1→3, 1→4)—β-glucanase of enhanced stability |
| 08/21/2001 | US6277614 Enzymatic protein associated with recombination; for use as tool in genetic engineering and gene therapy |
| 08/21/2001 | US6277613 TRF1 binding protein, methods of use thereof |
| 08/21/2001 | US6277612 Polypeptides having galactose oxidase activity and nucleic acids encoding same |
| 08/21/2001 | US6277610 Rapid thermal cycle processing methods and apparatus |
| 08/21/2001 | US6277609 Method to produce biotin |
| 08/21/2001 | US6277608 Cloning target nucleotide sequences; mixing expression vector and target nucleotide sequences, incubate with recombinase, amplify and recover target sequences |
| 08/21/2001 | US6277607 Amplification using primers that when not bound to target, form a hairpin structure in which the 3' terminal region of the primer is hybridized to the 5' terminal region of the primer to form a double-stranded stem, single stranded loop |
| 08/21/2001 | US6277604 Accumulating nucleotide sequences; incubate nucleotide sequences with support, oligonucleotides primers and polymerase, recover amplification product |
| 08/21/2001 | US6277603 Peptide nucleic acid (pna); the dna portion is composed of subunits of at least one 2'-deoxynucleotides; increased nuclease resistance; activate rnase h enzyme, use for in vitro modification of rna |
| 08/21/2001 | US6277601 Viral polypeptide for the treatment of viral diseases, genetic disorders and cancer; for use in vaccine development |
| 08/21/2001 | US6277600 Trimeric chimera protein and collagen matrix containing chimera protein |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277598 Nucleotide sequences associated with the activation of immunocompetent cells; for the reduction of side effects associated with cancer treatment; for amplifying cytotoxicity of killing cells; for the treatment viral diseases |
| 08/21/2001 | US6277596 Regulatory sequence of cellulase cbh1 genes originating in trichoderma viride and system for mass-producing proteins or peptides therewith |
| 08/21/2001 | US6277595 Nucleotide sequences coding fatty acid biosynthsis polypeptide; for the prevention of microorganism infection |
| 08/21/2001 | US6277594 Neurogenesis inducing gene |
| 08/21/2001 | US6277593 Generating preferential polypeptide; culture transformed cells, express preferential polypeptide, recover preferential polypeptide |
| 08/21/2001 | US6277592 Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
| 08/21/2001 | US6277591 Isolating nucleotide sequences coding g-protein coupled receptor; hybridize nucleotide sequences of sample and probe, isolate hybridization product, incubate with oligonucleotide probe and recover sequence coding transmembrane protein |